Today's News: Middle East
SEE OTHER BRANDS

Following the news from the Middle East

Today's News: Middle East: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today's News: Middle East.

Press releases published on July 15, 2025

Critical Metals Corp Targets Significantly Increased Resource Upgrade on 500MT Exploration Target within 4.7BT TREO

Critical Metals Corp Targets Significantly Increased Resource Upgrade on 500MT Exploration Target within 4.7BT TREO

Advances Feasibility Study and Seeks to Boost Resource Estimate Ahead of Q4 2025 Milestones Positions Mine for Commercial Production, which is Expected in 2026, to Address Growing Demand in the West NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- Critical …

XRP price breaks through, CJB Crypto launches XRP Cloud Mining

XRP price breaks through, CJB Crypto launches XRP Cloud Mining

London, UK, July 15, 2025 (GLOBE NEWSWIRE) -- In this context, CJB Crypto, a cloud mining service provider headquartered in London, has launched a compelling solution: combining the potential appreciation opportunities of XRP with the predictable income of …

Clearmind Expands its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled

Clearmind Expands its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled

Vancouver, Canada, July 15, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …

Fasoo Poised for Market Growth as Demand Surges for Intelligent Data-centric Backup Against Ransomware

Fasoo Poised for Market Growth as Demand Surges for Intelligent Data-centric Backup Against Ransomware

SEOUL, SOUTH KOREA, July 15, 2025 /⁨EINPresswire.com⁩/ -- — Fasoo, the leader in data-centric security, helps organizations strengthen resilience with Fasoo Content Backup and Recovery (FC-BR), its innovative EBR (Enterprise Backup and Recovery) solution …

Nautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025

Nautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025

SEATTLE, July 15, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced it will report financial results for the …

Lisata Therapeutics Expands Intellectual Property Portfolio with New Composition of Matter Patent for Certepetide

Lisata Therapeutics Expands Intellectual Property Portfolio with New Composition of Matter Patent for Certepetide

Newly issued U.S. patent extends certepetide IP protection to 2040, with subsequent opportunity for patent term extension This patent covers novel cyclic peptides and their use in treating solid tumors BASKING RIDGE, N.J, July 15, 2025 (GLOBE NEWSWIRE) -- …

Skyharbour’s Partner Company UraEx Resources Commences Summer 2025 Drilling Program at South Dufferin Uranium Project, Athabasca Basin, Saskatchewan

Skyharbour’s Partner Company UraEx Resources Commences Summer 2025 Drilling Program at South Dufferin Uranium Project, Athabasca Basin, Saskatchewan

Vancouver, BC, July 15, 2025 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour” or the “Company”) is pleased to announce that its earn-in option partner, UraEx Resources Inc. (“UraEx”), has commenced …

PolyPid Unveils a Long-Acting GLP-1 Receptor Agonists Delivery Platform Targeting the Diabetes and Weight Loss Market

PolyPid Unveils a Long-Acting GLP-1 Receptor Agonists Delivery Platform Targeting the Diabetes and Weight Loss Market

PolyPid's proprietary and clinically validated, prolonged-release drug delivery technology aims to subcutaneously deliver GLP-1 for approximately 60 days, compared to current standard of care of weekly injections. The GLP-1 delivery platform expands …

Polyrizon Retains Nasdaq Listing Following Hearings Panel

Polyrizon Retains Nasdaq Listing Following Hearings Panel

Raanana, Israel, July 15, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced that it has received a …

BSTR Miner Cloud Mining Unveils Industry-First XRP Mining Service: Zero-Hardware Cloud Solution to Earn Ripple Network Rewards

BSTR Miner Cloud Mining Unveils Industry-First XRP Mining Service: Zero-Hardware Cloud Solution to Earn Ripple Network Rewards

Los Angeles, USA, July 15, 2025 (GLOBE NEWSWIRE) -- Unlike traditional proof-of-work cryptocurrencies, BSTR Miner’s XRP mining leverages participation rewards from Ripple’s energy-efficient consensus protocol. The service connects users to enterprise-grade …

SELLAS Meets All Primary Endpoints in Phase 2 Trial of SLS009 in r/r AML and Receives FDA Guidance to Advance into First-Line Therapy Study

SELLAS Meets All Primary Endpoints in Phase 2 Trial of SLS009 in r/r AML and Receives FDA Guidance to Advance into First-Line Therapy Study

The Trial Exceeded Target Overall Response Rate (ORR) of 20%, with 44% Response Rate Among Patients with Acute Myeloid Leukemia-Myelodysplasia-Related Changes (AML MR) Treated at Optimal Dose of 30 mg Twice a Week (BIW) and 50% in AML MR with …

Hengrui Pharma and Kailera Therapeutics Report Positive Topline Data from Phase 3 Obesity Trial in China of Dual GLP-1/GIP Receptor Agonist HRS9531

Hengrui Pharma and Kailera Therapeutics Report Positive Topline Data from Phase 3 Obesity Trial in China of Dual GLP-1/GIP Receptor Agonist HRS9531

– Mean weight loss of 19.2% at 6 mg with no plateau in 48-week Phase 3 trial – – Favorable safety profile consistent with other GLP-1-based treatments – – Hengrui to submit NDA in China; Kailera plans to evaluate both higher doses and longer duration of …

Nexxen Expected to Expand its CTV OEM Relationships and ACR Data Reach in Europe Through Vestel’s Strategic Partnership with VIDAA

Nexxen Expected to Expand its CTV OEM Relationships and ACR Data Reach in Europe Through Vestel’s Strategic Partnership with VIDAA

NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and advanced TV, today announced it anticipates benefitting …

Neuronetics Appoints New Chief Financial Officer

Neuronetics Appoints New Chief Financial Officer

Steven Pfanstiel, a seasoned financial executive with extensive medical technology and pharmaceutical experience, replaces Steve Furlong as Chief Financial Officer following previously announced succession process Neuronetics reiterates guidance for second …

WestKam Gold Corp. Provides Update on Management Cease Trade Order,  Announces Appointment of Interim CFO and Announces Private Placement

WestKam Gold Corp. Provides Update on Management Cease Trade Order, Announces Appointment of Interim CFO and Announces Private Placement

Vancouver, BC, Canada, July 15, 2025 (GLOBE NEWSWIRE) -- WestKam Gold Corp. (TSXV:WKG) (the “Company” or “WestKam”), further to its news release of July 2, 2025 (the “MCTO Announcement”), provides an update with respect to the management cease trade order …

AAS MINER Launches AI-Powered Bitcoin Cloud Mining — Activate with BTC, ETH, DOGE, or XRP for Higher Returns

AAS MINER Launches AI-Powered Bitcoin Cloud Mining — Activate with BTC, ETH, DOGE, or XRP for Higher Returns

LONDON, UK, July 15, 2025 (GLOBE NEWSWIRE) -- A Smarter Future for Bitcoin Mining Starts Now The landscape of Bitcoin mining is changing—fast. Gone are the days when mining was limited to tech-savvy users and expensive hardware. AAS MINER is ushering in a …

Acumen Pharmaceuticals and JCR Pharmaceuticals Enter Strategic Collaboration, Option and License Agreement to Develop Enhanced Brain Delivery™ Therapy for Alzheimer’s Disease

Acumen Pharmaceuticals and JCR Pharmaceuticals Enter Strategic Collaboration, Option and License Agreement to Develop Enhanced Brain Delivery™ Therapy for Alzheimer’s Disease

Acumen and JCR aim to develop a product leveraging Acumen’s amyloid beta oligomer-selective antibody expertise and JCR’s transferrin-receptor-targeting blood-brain barrier-penetrating technology Preclinical candidate data expected in early 2026, with …

Apellis Announces Five Abstracts Accepted for Oral Presentation at the American Society of Retina Specialists (ASRS) Annual Scientific Meeting

Apellis Announces Five Abstracts Accepted for Oral Presentation at the American Society of Retina Specialists (ASRS) Annual Scientific Meeting

WALTHAM, Mass., July 15, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that five abstracts were accepted for oral presentation at the American Society of Retina Specialists (ASRS) Annual Scientific Meeting to be held …

Verano Announces Promotion and Appointment of James Leventis as Chief Strategy and Compliance Officer

Verano Announces Promotion and Appointment of James Leventis as Chief Strategy and Compliance Officer

CHICAGO, July 15, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the promotion and appointment of James Leventis as the Company’s Chief …

Mirasol Signs Agreement for the Sale of the Nord Projects in Chile for US$2.5 Million Plus Royalty

Mirasol Signs Agreement for the Sale of the Nord Projects in Chile for US$2.5 Million Plus Royalty

Eco Earth to acquire the Nord East and Nord West Projects for a total combined consideration of ~US$2.5 million over 4 years of scheduled payments Mirasol will retain a 2% NSR royalty on Nord East, Eco Earth will have the right to purchase the first 1% for …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service